Barely Significant
← all excerpts

NeuroD1 gene therapy inhibits glioma growth and extends life span through <i>in vivo</i> reprogramming approach.

Mol Ther Oncol · 2026 · PMC13136644 · PMID 42088619

Europe PMCDOI
1
hedged sentence
—
closest p
—
boldest claim

The sentences

a nonsignificant trendno p-value reported
In contrast, NEUROG2 —another bHLH family of neural transcription factor paralog of NEUROD1 —showed a nonsignificant trend toward improved survival ( Figures 8 C and 8 D).

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.